Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram

Biochimica et Biophysica Acta - General Subjects

Volumn 1810, Issue 12, 2011, Pages 1230-1235

  Walsh, Ryan ^a   Rockwood, Kenneth ^a   Martin, Earl ^b   Darvesh, Sultan ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MOUNT SAINT VINCENT UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Cholinesterase inhibitor; Dementia; Enzyme kinetics; Selective serotonin reuptake inhibitor

Indexed keywords

CHOLINESTERASE; CITALOPRAM; GALANTAMINE;

ALZHEIMER DISEASE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; MATHEMATICAL COMPUTING; MOLECULAR MODEL; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; CITALOPRAM; DRUG SYNERGISM; GALANTAMINE; HUMANS; MODELS, THEORETICAL;

EID: 80054984659     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.08.010     Document Type: Article

References (37)

1. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403 (Pubitemid 8004505)
2. P.J. Whitehouse, D.L. Price, A.W. Clark, J.T. Coyle, and M.R. DeLong Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis Ann. Neurol. 10 1981 122 126 (Pubitemid 11053099)
3. R.T. Bartus, R.L. Dean 111, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
4. J.T. Coyle, D.L. Price, and M.R. DeLong Alzheimer's disease: a disorder of cortical cholinergic innervation Science 219 1983 1184 1190 (Pubitemid 13160659)
5. J.R. Atack, E.K. Perry, J.R. Bonham, J.M. Candy, and R.H. Perry Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system J. Neurochem. 47 1986 263 277 (Pubitemid 16069199)
6. S. Darvesh, G.A. Reid, and E. Martin Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues Curr. Alzheimer Res. 5 2010 386 400
7. E.K. Perry, R.H. Perry, G. Blessed, and B.E. Tomlinson Changes in brain cholinesterases in senile dementia of Alzheimer type Neuropathol. Appl. Neurobiol. 4 1978 273 277 (Pubitemid 9001675)
8. M. Mesulam, A. Guillozet, P. Shaw, and B. Quinn Widespread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain Neurobiol. Dis. 9 2002 88 93 (Pubitemid 34174568)
9. J. Birks, and J. Birks Cholinesterase Inhibitors for Alzheimer's disease Cochrane Database Syst. Rev. 1 2006 cd.005593 10.1002/14651858.CD005593 (Pubitemid 46841366)
10. R.E. Becker, and N.H. Greig Why so few drugs for Alzheimer's disease? Are methods failing drugs? Curr. Alzheimer Res. 7 2010 642 651
11. V. Tumiatti, A. Minarini, M.L. Bolognesi, A. Milelli, M. Rosini, and C. Melchiorre Tacrine derivatives and Alzheimer's disease Curr. Med. Chem. 17 2010 1825 1838
12. N. Toda, T. Kaneko, and H. Kogen Development of an efficient therapeutic agent for Alzheimer's disease: design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter Chem. Pharm. Bull. 58 2010 273 287
13. P. Bentley, J. Driver, and R.J. Dolan Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory Brain 132 2009 2356 2371
14. B. Lam, E. Hollingdrake, J.L. Kennedy, S.E. Black, and M. Masellis Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story Hum. Genomics 4 2009 91 106
15. D. Toiber, A. Berson, D. Greenberg, N. Melamed-Book, S. Diamant, and H. Soreq N-acetylcholinesterase-induced apoptosis in Alzheimer's disease PLoS One 1 2008 e3108
16. S. Darvesh, D.A. Hopkins, and C. Geula Neurobiology of butyrylcholinesterase Nat. Rev. Neurosci. 4 2003 131 138 (Pubitemid 37271383)
17. S. Darvesh, R. Walsh, R. Kumar, A. Caines, S. Roberts, D. Magee, K. Rockwood, and E. Martin Inhibition of human cholinesterases by drugs used to treat Alzheimer disease Alzheimer Dis. Assoc. Disord. 17 2003 117 126 (Pubitemid 36736847)
18. Q. Yu, H.W. Holloway, T. Utsuki, A. Brossi, and N.H. Greig Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease J. Med. Chem. 42 1999 1855 1861 (Pubitemid 29244980)
19. E. Giacobini, R. Spiegel, A. Enz, A.E. Veroff, and N.R. Cutler Inhibition of acetyl- and butyrylcholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit J. Neural. Transm. 109 2002 1053 1065 (Pubitemid 34762344)
20. N.H. Greig, T. Utsuki, D.K. Ingram, Y. Wang, G. Pepeu, C. Scali, Q.S. Yu, J. Mamczarz, H.W. Holloway, T. Giordano, D. Chen, K. Furukawa, K. Sambamurti, A. Brossi, and D.K. Lahiri Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent Proc. Natl. Acad. Sci. U. S. A. 102 2005 17213 17218 (Pubitemid 41692709)
21. F. Cerbai, M.G. Giovannini, C. Melani, A. Enz, and G. Pepeu N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine Eur. J. Pharmacol. 572 2007 142 150 (Pubitemid 47429651)
22. J. Hartmann, C. Kiewert, E.G. Duysen, O. Lockridge, N.H. Greig, and J. Klein Excessive hippocampal acetylcholine levels in acetylcholinesterase- deficient mice are moderated by butyrylcholinesterase activity J. Neurochem. 100 2007 1421 1429
23. M. Garcia-Alloza, F.J. Gil-Bea, M. Diez-Ariza, C.P. Chen, P.T. Francis, B. Lasheras, and M.J. Ramirez Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease Neuropsychologia 43 2005 442 449 (Pubitemid 40222131)
24. M. Garcia-Alloza, N. Zaldua, M. Diez-Ariza, B. Marcos, B. Lasheras, F. Javier Gil-Bea, and M.J. Ramirez Effect of selective cholinergic denervation on the serotonergic system: implications for learning and memory J. Neuropathol. Exp. Neurol. 65 2006 1074 1081 (Pubitemid 44684665)
25. M.H. Trivedi, A.J. Rush, S.R. Wisniewski, A.A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R.H. Howland, B. Lebowitz, P.J. McGrath, K. Shores-Wilson, M.M. Biggs, G.K. Balasubramani, and M. Fava STAR*D Study Team, evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am. J. Psychiatry 163 2006 28 40 (Pubitemid 43050100)
26. G.S. Smith, E. Kramer, Y. Ma, C.R. Hermann, V. Dhawan, T. Chaly, and D. Eidelberg Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease Brain 132 2009 392 401
27. L. Rozzini, B.V. Chilovi, M. Conti, E. Bertoletti, M. Zanetti, M. Trabucchi, and A. Padovani Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors Int. Psychogeriatr. 22 2010 114 119
28. K. Rockwood, R. Walsh, E. Martin, and S. Darvesh Potentially pro-cholinergic effects of medications commonly used in older adults Am. J. Geriatr. Pharmacother. 9 2011 80 87
29. R. Walsh, E. Martin, and S. Darvesh A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling ß-galactosidase and butyrylcholinesterase Biochim. Biophys. Acta 1770 2007 733 746 (Pubitemid 46412634)
30. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
31. R.A. Copeland Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis 2nd ed 2000 Wiley-VCH New York
32. D. Fylstra, L. Lasdon, J. Watson, and A. Waren Design and use of the microsoft excel solver Interfaces 28 1998 29 55
33. A. Silver The Biology of Cholinesterases 1974 Elsevier Amsterdam
34. R. Khanin, H. Parnas, and L. Segel Diffusion cannot govern the discharge of neurotransmitter in fast synapses Biophys. J. 67 1994 966 972 (Pubitemid 24272946)
35. J.L. Smart, and J.A. McCammon Analysis of synaptic transmission in the neuromuscular junction using a continuum finite element model Biophys. J. 75 1998 1679 1688 (Pubitemid 28455164)
36. B.R. Land, E.E. Salpeter, and M.M. Salpeter Acetylcholine receptor site density affects the rising phase of miniature endplate currents Proc. Natl. Acad. Sci. U. S. A. 77 1980 3736 3740 (Pubitemid 10012934)
37. S. Darvesh, E. Martin, R. Walsh, and K. Rockwood Differential effects of lipid lowering agents on human cholinesterases Clin. Biochem. 37 2004 42 49 (Pubitemid 37522124)